The Ontario government’s idea appears straightforward: Encourage investors to buy rich farmland and grow sun-drenched cannabis plants full of the compounds that get you high, treat ailments, and pack an aromatic punch. Then let them open their gates, offering tourists an experience akin to boutique wineries.

Entrepreneurs jumping on the opportunity are finding it’s not so simple.

Legislation that took effect in 2019 allowing direct sales from farms is restrictive and unwieldy, and such projects are further complicated by the myriad rules governing the cannabis industry in Canada at the municipal, provincial, and federal levels.

WHY MIGHT YOU NEED TO BUY IN BULK?

Canadian cannabis producer The Valens Company Inc. VLNS, +3.62% VLNCF, +3.01% said Tuesday its effort to list its shares on the Nasdaq "has progressed at a slower pace than originally anticipated." The company expects to begin trading on Nasdaq by the end of fiscal 2021. The stock will continue to trade on Toronto Stock Exchange. Once its moves to the Nasdaq, its stock will no longer be quoted on the OTCQX. Valens hired Stikeman Elliott LLP in Canada and Foley Hoag LLP to advise the company on its Nasdaq listing application process. Valens shares are up 36% so far this year, compared to a dip of 2.4% by the Cannabis ETF THCX, +2.62%.

Unlicensed cannabis is not as strong as you may think it is. 

That's according to a recently published study by the New Brunswick Research and Productivity Council.

Researchers comparing samples of illicit and legal cannabis products found that the claims of potency for illicit products were significantly less accurate.  

The RPC's chief officer of science Diane Botelho said the study was taken on to find out whether there was any legitimacy to claims made about cannabis products on the illicit market being 'better'. 

"Our scientists have been curious for a number of years now as to whether or not illicit cannabis products were equivalent to legal cannabis products with respect to health and safety as well as potency claims," said Botelho. 

Love Pharma Inc. (CSE: LUV), formerly Glenbriar Technologies, Inc., is a new-age pharma/nutraceutical company that specializes in the global sexual health, wellness and psychedelics markets by licensing and distributing psychedelic and cannabis-infused products.  The company ushered in a new era of health and wellness as it began trading on the Canadian Securities Exchange last week under the new name and ticker symbol. 

As Love Pharma sets out to bring psychedelic therapies, pharmaceutical alternatives, and sexual enrichment products to market, it will immediately propel its current CBD-infused brands, “Bloom” and “Auralief,” into the marketplace while it continues to develop a host of additional patent-protected products in the company’s pipeline. 

Aurora Cannabis (NASDAQ:ACB) is one of the top marijuana stocks in Canada. It has fallen behind both Tilray (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) in terms of revenue, but it's still a relatively big player in the pot market up north. However, with the company reporting yet another lackluster period this week with respect to revenue growth, it could fall further behind, especially as marijuana producer Hexo (NASDAQ:HEXO) has been trying to grow via acquisitions.

Investors should also pay attention to another company that could soon be on Aurora's heels as well: Village Farm International (NASDAQ:VFF).

CBD (Cannabidiol) is a non-alcoholic extract of the hemp plant. In 2018, the hemp plant was officially recognized as an agricultural crop. Hemp plant is similar to the marijuana plant and both the plants are part of cannabis. However, hemp plants comprise up to 0.3% THC called the psychoactive ingredient. If a CBD plant’s THC level is more than 0.3%, then it is classified as a marijuana plant.Globally, the CBD infused cosmetics market is growing owing to the expansion of product portfolio and manufacturers targeting premium customers by launching premium products. Moreover, the growing adoption of organic CBD cosmetic products is projected to drive the demand for CBD infused cosmetics.